{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:54:30Z","timestamp":1770234870355,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T00:00:00Z","timestamp":1378857600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0069892","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T19:32:20Z","timestamp":1378927940000},"page":"e69892","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antigen-Specific CD4 T Cells Are Induced after Intravesical BCG-Instillation Therapy in Patients with Bladder Cancer and Show Similar Cytokine Profiles as in Active Tuberculosis"],"prefix":"10.1371","volume":"8","author":[{"given":"Julia","family":"Els\u00e4\u00dfer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Suttmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Sester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"St\u00f6ckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Sester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"A Morales","year":"1976","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"RJ Sylvester","year":"2002","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00262-008-0643-x","article-title":"A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth","volume":"58","author":"T Higuchi","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biopha.2007.05.004","article-title":"Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement","volume":"61","author":"S Brandau","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"A B\u00f6hle","year":"2003","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0022-5347(05)65522-X","article-title":"T helper 1\/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer","volume":"166","author":"F Saint","year":"2001","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2005.05.004","article-title":"BCG dose reduction by decreasing the instillation frequency: effects on local Th1\/Th2 cytokine responses in a mouse model","volume":"48","author":"EC de Boer","year":"2005","journal-title":"Eur Urol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-003-0384-9","article-title":"Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guerin immunotherapy for carcinoma in situ of the bladder","volume":"52","author":"E Watanabe","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"137ra172","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"C Biot","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000020170","article-title":"What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?","volume":"37","author":"AR Zlotta","year":"2000","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2012.08.043","article-title":"Re: Preexisting BCG-specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer","volume":"62","author":"EM Messing","year":"2012","journal-title":"Eur Urol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-5347(17)45605-9","article-title":"Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin","volume":"135","author":"DR Kelley","year":"1986","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.08-2575","article-title":"Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients","volume":"136","author":"L Richeldi","year":"2009","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"D Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"U Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e17813","DOI":"10.1371\/journal.pone.0017813","article-title":"Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active States","volume":"6","author":"U Sester","year":"2011","journal-title":"PLOS ONE"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.178.8.5217","article-title":"Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load","volume":"178","author":"KA Millington","year":"2007","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease","volume":"17","author":"A Harari","year":"2011","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/eji.201040455","article-title":"Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection","volume":"40","author":"N Caccamo","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jinf.2013.02.004","article-title":"IFNgamma\/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis","volume":"66","author":"E Petruccioli","year":"2013","journal-title":"J Infect"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"CL Day","year":"2011","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"M Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1523-1755.2004.00586.x","article-title":"Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients","volume":"65","author":"M Sester","year":"2004","journal-title":"Kidney Int"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/rheumatology\/kem351","article-title":"Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay","volume":"47","author":"R Dinser","year":"2008","journal-title":"Rheumatology (Oxf)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/ndt\/gfl416","article-title":"Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy","volume":"21","author":"U Sester","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","article-title":"The role of bacillus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer","volume":"57","author":"P Gontero","year":"2010","journal-title":"Eur Urol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri1840","article-title":"Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases","volume":"6","author":"G Pantaleo","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/eji.201242393","article-title":"CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection","volume":"42","author":"T Schmidt","year":"2012","journal-title":"Eur J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.rmed.2003.12.003","article-title":"Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: a model to study tuberculosis immunity","volume":"98","author":"A Ponticiello","year":"2004","journal-title":"Respir Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/mi.2011.10","article-title":"Initiation and regulation of T-cell responses in tuberculosis","volume":"4","author":"KB Urdahl","year":"2011","journal-title":"Mucosal Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/infdis\/jis941","article-title":"Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns","volume":"207","author":"AP Soares","year":"2013","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1600-6143.2008.02279.x","article-title":"PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy","volume":"8","author":"U Sester","year":"2008","journal-title":"Am J Transplant"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/01.ju.0000059681.67567.12","article-title":"The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin","volume":"169","author":"CY Bilen","year":"2003","journal-title":"J Urol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5","article-title":"What are the immunologically active components of bacille Calmette-Guerin in therapy of superficial bladder cancer?","volume":"87","author":"AR Zlotta","year":"2000","journal-title":"Int J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall","volume":"147","author":"S Prescott","year":"1992","journal-title":"J Urol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0302-2838(03)00048-4","article-title":"Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guerin (BCG) immunotherapy exist?. analysis of a quarter century of literature","volume":"43","author":"F Saint","year":"2003","journal-title":"Eur Urol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-5347(01)66427-9","article-title":"Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors","volume":"155","author":"W L\u00fcftenegger","year":"1996","journal-title":"J Urol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eururo.2011.03.051","article-title":"Bacillus Calmette-Guerin without maintenance therapy for high-risk non-muscle-invasive bladder cancer","volume":"60","author":"HW Herr","year":"2011","journal-title":"Eur Urol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","article-title":"Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance","volume":"63","author":"J Oddens","year":"2013","journal-title":"Eur Urol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.coi.2011.05.008","article-title":"Immune responses in the skin in old age","volume":"23","author":"M Vukmanovic-Stejic","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.20090896","article-title":"Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging","volume":"206","author":"E Agius","year":"2009","journal-title":"J Exp Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/onci.20526","article-title":"Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients","volume":"1","author":"C Pieraerts","year":"2012","journal-title":"Oncoimmunology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0069892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T20:14:53Z","timestamp":1563912893000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0069892"}},"subtitle":[],"editor":[{"given":"Delia","family":"Goletti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,11]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0069892","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,11]]}}}